Pharma Capsules - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Capsules
Brief pharmaceutical news items for March 2008.

Pharmaceutical Technology


Cognex Launches New Website


Cognexs new website.
Cognex's (Natick, MA) new website, http://www.cognex.com/, is designed to illustrate how manufacturers can use vision to optimize product quality and reduce manufacturing costs.

The site includes more than 80 application case studies, selectable by industry and application, that show how customers benefit from Cognex's machine vision solution. One section of the site gives visitors options for learning more about vision technology through seminars, training programs, and tradeshows.

The website is easy to navigate and provides details about Cognex's products. Information for more than 35 countries is available in nine languages.

People

Egenix Appoints Scientific Advisor

Egenix (Millbrook, NY), named Daniel Petrylak chairman of the company's scientific advisory board. Petrylak is an associate professor of medicine at Columbia University Medical Center, where he is director of genitourinary oncology.

Egenix is a privately held biotechnology company working to create effective cancer therapies. The company is working to develop small-molecule inhibitors of translation initiation, a new paradigm in target-specific, noncytotoxic anticancer therapy.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
26%
Oversee medical treatment of patients in the US.
12%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here